v3.26.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities    
Net earnings including non-controlling interests $ 2,041 $ 619
Adjustments to reconcile net earnings to net cash provided by operating activities    
Depreciation and amortization 881 874
Asset impairment charges 4 337
Deferred income taxes (51) (54)
Equity in earnings of unconsolidated affiliates, net of dividends (59) 125
Stock compensation expense 176 93
(Gain) loss on asset contributions, sales and investment revaluation, net (76) 103
Other – net 97 (10)
Changes in operating assets and liabilities, net of acquisitions and dispositions    
Segregated investments 96 113
Trade receivables (632) 231
Inventories (1,410) 3,165
Other current assets (1,076) (190)
Trade payables 496 (637)
Payables to brokerage customers 547 1,798
Accrued expenses and other payables 754 (802)
Net cash provided by operating activities 1,788 5,765
Cash flows from investing activities    
Capital expenditures (773) (892)
Net assets of businesses acquired 0 (108)
Proceeds from sales of assets, businesses and investments 68 78
Purchases of marketable securities (14) (11)
Proceeds from sales of marketable securities 2 276
Other – net 18 13
Net cash used in investing activities (699) (644)
Cash flows from financing activities    
Proceeds from short-term debt 705 0
Repayments of short-term debt (399) 0
Long-term debt borrowings 995 0
Long-term debt payments (1,008) (763)
Net borrowings / (repayments) under lines of credit agreements 55 (1,666)
Share repurchases, net of tax (358) 0
Cash dividends (764) (743)
Acquisition of non-controlling interest 0 (4)
Other – net (58) (21)
Net cash used in financing activities (832) (3,197)
Effect of exchange rate on cash, cash equivalents, restricted cash, and restricted cash equivalents (22) 27
Increase in cash, cash equivalents, restricted cash, and restricted cash equivalents 235 1,951
Cash, cash equivalents, restricted cash, and restricted cash equivalents - beginning of period 5,505 3,924
Cash, cash equivalents, restricted cash, and restricted cash equivalents - end of period $ 5,740 $ 5,875